Relapsed B-Cell Acute Lymphoblastic Leukemia

specific

Centers

Active Trials

$900K

Cancer Funding

Top Centers for Relapsed B-Cell Acute Lymphoblastic Leukemia(2)

Ranked by research excellence score (trials · grants · publications). Methodology →

#	Center	Research Tier	Active Trials	Cancer Funding	Score
1	Memorial Sloan Kettering Cancer CenterNew York, NY NCI Comprehensive High-Volume Research Center	High-Volume Research Center	1	—	77.5
2	University of Colorado Cancer CenterAurora, CO NCI Comprehensive High-Volume Research Center	High-Volume Research Center	—	$900K	72.5

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →